Results 301 to 310 of about 821,910 (380)

Dolphin Pituitary Gland: Immunohistochemistry and Ultrastructural Cell Characterization Following a Novel Anatomical Dissection Protocol and Non-Invasive Imaging (MRI). [PDF]

Animals (Basel)
Alonso-Almorox P, Blanco A, Fiorito C, Sierra E, Suárez-Santana C, Consolli F, Arbelo M, Guzmán RG, Molpeceres-Diego I, Fernández Gómez A, Almunia J, Castro-Alonso A, Fernández A.   +12 more
europepmc   +1 more source

Annual Research Review: Neural mechanisms of eating disorders in youth – from current theory and findings to future directions

Journal of Child Psychology and Psychiatry, EarlyView.
Eating disorders are prevalent and profoundly debilitating psychiatric conditions with multifactorial etiology that frequently manifest during adolescence. This developmental stage is characterized by significant neurostructural and neurofunctional change, which may create a context conducive to the emergence of eating pathology.
Kelsey Hagan, E. Caitlin Lloyd, Sasha Gorrell   +2 more
wiley   +1 more source

Pituitary Gland Volume on Magneticresonance Imaging: Normative Observations

, 2007
Muhammad Faisal Ikram, Zafar Sajjad, Ishrat Shokh, Aamir Omair   +3 more
openalex   +1 more source

Effects of short‐term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP‐ELM study

Journal of Diabetes Investigation, EarlyView.
Tofogliflozin was compared with metformin in treatment‐naïve people with type 2 diabetes for 4 weeks. Overall insulin secretory capacity did not improve; however, tofogliflozin was associated with an improved disposition index in individuals with poorer baseline glucose tolerance or greater improvement after treatment.
Maiko Miyamoto, Aika Miya, Akinobu Nakamura, Yuka Takahashi, Yuki Yamauchi, Shingo Yanagiya, Takahiro Takase, Mayuko Ono, Kiyohiko Takahashi, Kazufumi Okada, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, on behalf of TOP‐ELM study group, Maiko Miyamoto, Aika Miya, Akinobu Nakamura, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Kazufumi Okada, Rimi Izumihara, Yuki Oe, Takahiro Takase, So Nagai, Akihiro Takahashi, Yuka Takahashi, Yuki Yamauchi, Hiromichi Kijima, Shinji Taneda, Jun Takeuchi, Kei Yokozeki, Saki Kuwabara, Yoshiaki Arimura, Shinichiro Kawata, Tomonori Sekizaki, Yuki Yamauchi, Shingo Yanagiya, Mayuko Ono, Kiyohiko Takahashi   +39 more
wiley   +1 more source

Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging. [PDF]

J Imaging
Abou Chaaya J, Abou Chaaya J, Jaafar B, Saab L, Abou Chaaya J, Al Ahmar E, Estephan E.   +6 more
europepmc   +1 more source

Safety of anagliptin/metformin combination tablets evaluated by non‐inferiority between pre‐ and post‐serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY)

Journal of Diabetes Investigation, EarlyView.
To investigate the safety of anagliptin/metformin combination tablets in Japanese patients of type 2 diabetes with moderate renal impairment. This study demonstrates that the fixed‐dose combination of anagliptin and metformin can be used safely in patients with type 2 diabetes complicated by moderate renal dysfunction.
Hiroshi Kajio, Ryotaro Bouchi, Mitsuhisa Komatsu, Masanori Yamazaki, Daisuke Takarabe, Masahide Okamoto, Takahisa Tanaka, Toru Kitazawa, Hisayuki Katsuyama, Yasumichi Mori, Mitsuhiko Noda   +10 more
wiley   +1 more source

The bright pituitary gland--a normal MR appearance in infancy.

, 1988
Stephan Wolpert, Mark A. Osborne, Mary Anderson, Val M. Runge   +3 more
openalex   +1 more source

Transcriptome analysis of pigeon pituitary gland: expression changes of genes encoding protein and peptide hormones at different breeding stages

Zhanggui Zeng, Qi-yi Peng, Fuxing Yang, Jie Wu, Hongrui Guo, Huidan Deng, Ling Zhao, Keren Long, Xun Wang   +8 more
openalex   +1 more source

FOXO1 regulates expression of Neurod4 in the pituitary gland. [PDF]

Mol Cell Endocrinol
Stallings CE, Das P, Athul SW, Ukagwu AE, Jensik PJ, Ellsworth BS.   +5 more
europepmc   +1 more source

The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors. [PDF]

Brain Pathol
Casar-Borota O, Burman P, Lopes MB.
europepmc   +1 more source